Of 31 case patients with newly diagnosed cardiac-valve regurgitation, 6 were currently exposed to pergolide, 6 were currently exposed to cabergoline, and 19 had not been exposed to any dopamine agonist within the previous year.

• 有31例患者出现新诊断的心脏瓣膜返流，其中6例研究时正在服用培高利特，6例使用卡麦角林，另外19例在研究的前一年中未再使用任何多巴胺受体激动剂。